DEVELOPMENT OF A PORCINE DELAYED WOUND-HEALING MODEL AND ITS USE IN TESTING A NOVEL CELL-BASED THERAPY

被引:44
|
作者
Hadad, Ivan [1 ]
Johnstone, Brian H. [4 ]
Brabham, Jeffrey G. [2 ]
Blanton, Matthew W. [1 ]
Rogers, Pamela I. [4 ]
Fellers, Cory [4 ]
Solomon, James L. [4 ]
Merfeld-Clauss, Stephanie [4 ]
DesRosiers, Colleen M. [2 ]
Dynlacht, Joseph R. [2 ]
Coleman, John J. [3 ]
March, Keith L. [4 ]
机构
[1] Indiana Univ Sch Med, Dept Surg, Indianapolis, IN 46202 USA
[2] Indiana Univ Sch Med, Div Radiat Oncol, Indianapolis, IN 46202 USA
[3] Indiana Univ Sch Med, Div Plast Surg, Indianapolis, IN 46202 USA
[4] Indiana Ctr Vasc Biol & Med, Indianapolis, IN USA
来源
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2010年 / 78卷 / 03期
关键词
Adult stem cells; Wound healing; Disease models; Radiation injuries; ADIPOSE STROMAL CELLS; PLATELET-RICH PLASMA; GROWTH-FACTOR; ENDOTHELIAL-CELLS; TEMPORAL-CHANGES; STEM-CELLS; SKIN; TISSUE; RADIATION; QUANTIFICATION;
D O I
10.1016/j.ijrobp.2010.05.002
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: A delayed full-thickness wound-healing model was developed and used for examining the capacity of adipose-derived stem cells (ASCs), either alone or in platelet-rich fibrin gels, to promote healing. Methods and Materials: Four pigs received electron beam radiation to the dorsal skin surface. Five weeks after radiation, subcutaneous fat was harvested from nonirradiated areas and processed to yield ASCs. Two weeks later, 28 to 30 full-thickness 1.5-cm(2) wounds were made in irradiated and nonirradiated skin. Wounds were treated with either saline solution, ASCs in saline solution, platelet-rich plasma (PRP) fibrin gel, ASCs in PRP, or non-autologous green fluorescence protein labeled ASCs. Results: The single radiation dose produced a significant loss of dermal microvasculature density (75%) by 7 weeks. There was a significant difference in the rate of healing between irradiated and nonirradiated skin treated with saline solution. The ASCs in PRP-treated wounds exhibited a significant 11.2% improvement in wound healing compared with saline solution. Enhancement was dependent on the combination of ASCs and PRP, because neither ASCs nor PRP alone had an effect. Conclusions: We have created a model that simulates the clinically relevant late radiation effects of delayed wound healing. Using this model, we showed that a combination of ASCs and PRP improves the healing rates of perfusion-depleted tissues, possibly through enhancing local levels of growth factors. (C) 2010 Elsevier Inc.
引用
收藏
页码:888 / 896
页数:9
相关论文
共 50 条
  • [31] Development of a Rabbit Human Glioblastoma Model for Testing of Endovascular Selective Intra-Arterial Infusion (ESIA) of Novel Stem Cell-Based Therapeutics
    Srinivasan, Visish M.
    Kan, Peter
    Gumin, Joy
    Collins, Dalis E.
    Chen, Stephen
    Chen, Melissa M.
    Garcia, Robert
    Fueyo, Juan
    Lang, Frederick F.
    NEUROSURGERY, 2023, 69 : 182 - 182
  • [32] Development of a rabbit human glioblastoma model for testing of endovascular selective intra-arterial infusion (ESIA) of novel stem cell-based therapeutics
    Kan, Peter
    Srinivasan, Visish M.
    Gumin, Joy
    Garcia, Roberto
    Chen, Stephen R.
    Johnson, Jeremiah N.
    Collins, Dalis E.
    Chen, Melissa M.
    Ledbetter, Daniel
    Huse, Jason
    Evan Luna, Zean Aaron
    Robledo, Ariadna
    Vasandani, Viren
    Rao, Abhijit
    Singh, Sanjay K.
    Shpall, Elizabeth J.
    Fueyo, Juan
    Gomez-Manzano, Candelaria
    Lang, Frederick F.
    NEURO-ONCOLOGY, 2024, 26 (01) : 127 - 136
  • [33] Development of a novel encapsulated non-viral cell-based, BBB-penetrant therapy for MPS I
    Pearson, Erika
    Hsu, Anya
    Tietz, Drew
    Donovan, Marissa
    Sohn, Lauren
    Hussack, Greg
    Stanimirovic, Danica
    Makino, Elina
    Ashton-Rickardt, Philip G.
    MOLECULAR GENETICS AND METABOLISM, 2022, 135 (02) : S94 - S94
  • [34] TRANSFORMING GROWTH-FACTOR-ALPHA (TGF-ALPHA) ENHANCES ALVEOLAR EPITHELIAL TYPE-II CELL REPAIR IN A NOVEL IN-VITRO MODEL OF WOUND-HEALING
    KHERADMAND, F
    FOLKESSON, HG
    MATTHAY, MA
    CLINICAL RESEARCH, 1994, 42 (01): : A32 - A32
  • [35] AIRMESS - Academy of International Regenerative Medicine & Surgery Societies: recommendations in the use of platelet-rich plasma (PRP), autologous stem cell-based therapy (ASC-BT) in androgenetic alopecia and wound healing
    Gentile, Pietro
    Alves, Rubina
    Cole, John P.
    Andjelkov, Katarina
    Van Helmelryck, Thierry
    Fernandez, Jonathan
    Trivisonno, Angelo
    Guillaume, Lemierre
    Verpaele, Alexis
    Tonnard, Patrick
    Magalon, Jeremy
    Magalon, Guy
    Menkes, Sophie
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2021, 21 (11) : 1443 - 1449
  • [36] Cell-Based Ex Vivo Gene Therapy with BMP2 Gene Transduced Dermal Fibroblasts To Accelerate Bone Healing in Equine Model
    Ishihara, Akikazu
    Zekas, Lisa J.
    Weisbrode, Steven E.
    Bertone, Alicia L.
    MOLECULAR THERAPY, 2009, 17 : S268 - S269
  • [37] Development and assessment of a novel ex vivo corneal culture technique involving an agarose-based dome scaffold for use as a model of in vivo corneal wound healing in dogs and rabbits
    Berkowski, William M., Jr.
    Gibson, Daniel J.
    Craft, Serena L.
    Whitley, Robert D.
    Schultz, Gregory S.
    Plummer, Caryn E.
    AMERICAN JOURNAL OF VETERINARY RESEARCH, 2020, 81 (01) : 47 - 57
  • [38] Use of a novel cell-based model to study the impact of genetic variants of OATP1B1 on drug disposition
    Li, Na
    Wang, Jie
    Cooper, Kirsten
    Bourgea, Joanne
    Singh, Ritu
    Stresser, David M.
    Crespi, Charles L.
    Patten, Christopher
    DRUG METABOLISM REVIEWS, 2016, 48 : 155 - 155
  • [39] Novel stem cell-based twin embryo model reveals inner cell mass division and enhanced endometrial adhesion in monochorionic twin development
    Luijkx, D.
    Ak, A.
    Guo, G.
    Van Golde, R.
    Van Blitterswijk, C.
    Giselbrecht, S.
    Vrij, E.
    HUMAN REPRODUCTION, 2024, 39 : I52 - I52
  • [40] IN-VITRO BIOLOGICAL ACTIVITY CHARACTERIZATION AND CELL-BASED POTENCY ASSAY DEVELOPMENT FOR ALLOCETRA-OTS: A NOVEL MACROPHAGE REPROGRAMMING NOVEL CELL THERAPY DEVELOPED FOR THE TREATMENT OF SEPSIS
    Ankri, C.
    Segev, N.
    Maztrafi, L.
    Paz, O.
    Mevorach, D.
    Hershkovitz, O.
    CYTOTHERAPY, 2023, 25 (06) : S212 - S212